+ Discretionary short-term incentive payments + Relocation assistance
Travel required up to 10%.
TerraPower develops advanced nuclear technologies to provide carbon-free energy and medical isotopes. The company works on next-generation reactors such as the Traveling Wave Reactor, Molten Chloride Fast Reactor, and sodium fast reactor. Its products generate electricity through fission in these next-gen designs, and the medical isotope work involves extracting isotopes like Actinium-225 for cancer treatment via partnerships (e.g., with Radiopharm). TerraPower generates revenue through technology licensing, partnerships, and supply agreements, serving utilities, government agencies, and medical institutions. The company differentiates itself by pursuing a diverse portfolio of reactor technologies and by combining power generation with medical isotope applications, complemented by collaborations and licensing to bring technologies to market. Its goal is to provide scalable, carbon-free energy while addressing medical needs through isotope production and new reactor deployments.
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$1.6B
Headquarters
Bellevue, Washington
Founded
2008
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Vision Insurance
Dental Insurance
Life Insurance
Disability Insurance
Parental Leave
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Relocation Assistance
Professional Development Budget
Conference Attendance Budget
Marmen Selected by TerraPower in Next Round of Vendor Contracts for Natrium(R) Reactor, Advances Supply Chain for Kemmerer Unit 1
TerraPower accelerates natrium(r) reactor deployment following landmark meetings with korean leaders. Aug 14, 2026, 06:08 ET New agreements and strong bilateral relationships advance long-term collaborations for future commercial-scale Natrium plants BELLEVUE, Wash., Aug. 14, 2026 /PRNewswire/ - TerraPower, a nuclear innovation company, today announced two key agreements, one with Hyundai Engineering & Construction (HDEC) and one with SK Innovation, to develop and commercialize the Natrium technology across the United States, Korea and select international markets, during a visit to Korea by TerraPower leadership. TerraPower founder and Chairman Bill Gates, along with TerraPower President and CEO Chris Levesque met with Prime Minister Han Seong-sook and leaders from the Export-Import Bank of Korea, HD Hyundai, HDEC and SK Innovation during a packed day in Seoul. Following the day of meetings in Seoul, TerraPower announced a framework agreement with HDEC to support the commercial deployment of Natrium reactors. Under the agreement, TerraPower selected HDEC as its engineering, procurement and construction (EPC) contractor to build up to eight of its future Natrium reactors with completion, price and performance guarantees, intended to facilitate conventional commercial financing of the Natrium reactor fleet. The collaboration will accelerate the commercial deployment of Natrium reactors by streamlining costs, improving design and construction efficiencies and strengthening global supply chains to deploy a fleet of Natrium plants across the United States and in select international markets. Separately, TerraPower and SK Innovation announced a term sheet agreement to advance their intent to develop Korea's first commercial Natrium plant along with plans to expand internationally. The two companies plan to explore opportunities to collaborate on engineering and digital innovation solutions, including digital twin technology and artificial intelligence, building on TerraPower's existing leadership in these tools to optimize operations and maintenance. "Today marks a pivotal moment for TerraPower as we embark on a new chapter of international collaboration with Korea's leading organizations," said Chris Levesque, president and CEO of TerraPower. "Combining TerraPower's innovative advanced nuclear technology with Korea's nuclear construction and operational expertise will strengthen our global cooperation and accelerate the deployment of a Natrium fleet that will transform the world's energy landscape." TerraPower will now begin work under these agreements to accelerate the deployment of next-generation nuclear technologies in the United States, Korea and around the world, reinforcing a pathway for reliable, scalable and economically competitive advanced nuclear power. About the Natrium Technology The Natrium technology is the first mover in the advanced reactor sector and is well positioned to support rapidly increasing energy demand. The Natrium plant design features a 345 MW sodium-cooled fast reactor with a patented molten salt-based energy storage system. The storage technology can boost the system's output to 500 MW of power when needed as it is designed to keep base output steady, ensuring constant reliability, and can quickly ramp up when demand peaks - it is the only advanced reactor design with this unique feature. The first Natrium plant is being developed through the U.S. Department of Energy's Advanced Reactor Demonstration Program (ARDP), a public-private partnership. That project is expected to be completed in 2030 and will be the first utility-scale advanced nuclear power plant in the United States. TerraPower is rapidly commercializing the Natrium technology, which includes an agreement with Meta for up to eight Natrium plants by 2035. About TerraPower TerraPower is a leading nuclear innovation company that strives to improve the world through nuclear energy and science. Since it was founded by Bill Gates and a group of like-minded visionaries, TerraPower has emerged as an incubator and developer of ideas and technologies that offer energy independence, environmental sustainability, medical advancement and other cutting-edge opportunities. It accepts and tackles some of the world's most difficult challenges. Behind each of its innovations and programs, TerraPower actively works to bring together the strengths and experiences of the world's public and private sectors to answer pressing global needs. Learn more at terrapower.com. Press contact SOURCE TerraPower
TerraPower accelerates natrium(r) reactor deployment following landmark meetings with korean leaders. Aug 14, 2026, 6:08 AM ET New agreements and strong bilateral relationships advance long-term collaborations for future commercial-scale Natrium plants BELLEVUE, Wash., Aug. 14, 2026 /PRNewswire/ - TerraPower, a nuclear innovation company, today announced two key agreements, one with Hyundai Engineering & Construction (HDEC) and one with SK Innovation, to develop and commercialize the Natrium technology across the United States, Korea and select international markets, during a visit to Korea by TerraPower leadership. TerraPower founder and Chairman Bill Gates, along with TerraPower President and CEO Chris Levesque met with Prime Minister Han Seong-sook and leaders from the Export-Import Bank of Korea, HD Hyundai, HDEC and SK Innovation during a packed day in Seoul. Following the day of meetings in Seoul, TerraPower announced a framework agreement with HDEC to support the commercial deployment of Natrium reactors. Under the agreement, TerraPower selected HDEC as its engineering, procurement and construction (EPC) contractor to build up to eight of its future Natrium reactors with completion, price and performance guarantees, intended to facilitate conventional commercial financing of the Natrium reactor fleet. The collaboration will accelerate the commercial deployment of Natrium reactors by streamlining costs, improving design and construction efficiencies and strengthening global supply chains to deploy a fleet of Natrium plants across the United States and in select international markets. Separately, TerraPower and SK Innovation announced a term sheet agreement to advance their intent to develop Korea's first commercial Natrium plant along with plans to expand internationally. The two companies plan to explore opportunities to collaborate on engineering and digital innovation solutions, including digital twin technology and artificial intelligence, building on TerraPower's existing leadership in these tools to optimize operations and maintenance. "Today marks a pivotal moment for TerraPower as we embark on a new chapter of international collaboration with Korea's leading organizations," said Chris Levesque, president and CEO of TerraPower. "Combining TerraPower's innovative advanced nuclear technology with Korea's nuclear construction and operational expertise will strengthen our global cooperation and accelerate the deployment of a Natrium fleet that will transform the world's energy landscape." TerraPower will now begin work under these agreements to accelerate the deployment of next-generation nuclear technologies in the United States, Korea and around the world, reinforcing a pathway for reliable, scalable and economically competitive advanced nuclear power. About the Natrium Technology The Natrium technology is the first mover in the advanced reactor sector and is well positioned to support rapidly increasing energy demand. The Natrium plant design features a 345 MW sodium-cooled fast reactor with a patented molten salt-based energy storage system. The storage technology can boost the system's output to 500 MW of power when needed as it is designed to keep base output steady, ensuring constant reliability, and can quickly ramp up when demand peaks - it is the only advanced reactor design with this unique feature. The first Natrium plant is being developed through the U.S. Department of Energy's Advanced Reactor Demonstration Program (ARDP), a public-private partnership. That project is expected to be completed in 2030 and will be the first utility-scale advanced nuclear power plant in the United States. TerraPower is rapidly commercializing the Natrium technology, which includes an agreement with Meta for up to eight Natrium plants by 2035. About TerraPower TerraPower is a leading nuclear innovation company that strives to improve the world through nuclear energy and science. Since it was founded by Bill Gates and a group of like-minded visionaries, TerraPower has emerged as an incubator and developer of ideas and technologies that offer energy independence, environmental sustainability, medical advancement and other cutting-edge opportunities. It accepts and tackles some of the world's most difficult challenges. Behind each of its innovations and programs, TerraPower actively works to bring together the strengths and experiences of the world's public and private sectors to answer pressing global needs. Learn more at terrapower.com. Press contact SOURCE TerraPower NOTE: This content is not written by or endorsed by "WOWK", its advertisers, or Nexstar Media Inc.
From refinery ruins to life sciences powerhouse: Philadelphia's Bellwether District attracts $450M biotech investment. Philadelphia's former oil refinery site is undergoing a major transformation into a next-generation life sciences and advanced manufacturing ecosystem. TerraPower Isotopes, backed by Bill Gates-founded TerraPower, plans to invest $450 million in a new medical isotope production facility, signaling growing momentum for brownfield redevelopment and biotech infrastructure investment in the United States. Editorial Review: Akshay Reddy Published on: Jul 16, 2026 Nuclear Medicine Radioisotopes Market Size, Share, Industry, Forecast and outlook (2026-2033) The transformation of legacy industrial assets into innovation-driven economic engines is accelerating across the United States. One of the most significant examples is unfolding in Philadelphia, where the former Philadelphia Energy Solutions (PES) refinery site is being redeveloped into a large-scale life sciences and advanced manufacturing district. The 1,300 acre property, now known as the Bellwether District, was once home to the largest oil refinery on the U.S. East Coast. Following a catastrophic refinery explosion in 2019 that led to the facility's closure and bankruptcy, developers initiated one of the nation's most ambitious brownfield redevelopment projects. A major milestone in the site's evolution has emerged with TerraPower Isotopes' commitment to invest approximately $450 million in a state-of-the-art manufacturing facility dedicated to producing medical isotopes used in advanced cancer therapies. The facility is expected to serve the growing global demand for precision oncology treatments and radiopharmaceutical innovation. Strategic shift from fossil fuels to biotechnology. The Bellwether District represents a broader shift occurring across industrial economies, where underutilized energy and manufacturing assets are being repurposed to support high-growth sectors such as biotechnology, life sciences, clean technology, and advanced manufacturing. Developers have spent years dismantling aging refinery infrastructure, removing hundreds of storage tanks, decommissioning pipelines, and remediating environmental risks to prepare the site for modern industrial tenants. These efforts have significantly improved the site's attractiveness to technology-driven manufacturers and institutional investors. Industry analysts note that large-scale redevelopment projects offer a unique opportunity to combine sustainability objectives with economic growth strategies. Instead of developing greenfield locations, companies can leverage existing transportation networks, utility infrastructure, and workforce availability while supporting environmental restoration goals. Explore the Nuclear Medicine Radioisotopes Market Report Discover exclusive insights into Nuclear Medicine Radioisotopes Market growth, emerging radiopharmaceutical innovations, key players, regional opportunities, and future demand trends driving the global nuclear medicine radioisotopes industry through 2033. Request a Nuclear Medicine Radioisotopes Market Sample Report. Why life sciences companies are choosing Philadelphia. Philadelphia continues to strengthen its position as one of North America's leading life sciences ecosystems. The region benefits from a deep talent pool, world-class research institutions, major healthcare systems, and established pharmaceutical manufacturing capabilities. These advantages have helped attract significant biotech investments despite broader industry challenges. For TerraPower Isotopes, access to specialized scientific talent, logistics infrastructure, and proximity to research organizations played a critical role in site selection. The project is expected to create hundreds of high-skilled jobs while supporting long-term innovation within the regional healthcare and biotechnology sectors. A blueprint for future industrial redevelopment. The Bellwether District redevelopment illustrates how former industrial sites can be repositioned as innovation campuses capable of supporting next-generation industries. Plans for the district include millions of square feet of manufacturing, research, logistics, and commercial space, with projections indicating substantial economic impact through job creation and tax revenue generation over the coming decade. As governments and private investors increasingly prioritize resilient supply chains, domestic pharmaceutical manufacturing, and sustainable infrastructure development, projects like Bellwether may become a model for future brownfield-to-biotech transformations worldwide. What is the Bellwether District in Philadelphia? The Bellwether District is a 1,300 acre redevelopment project built on the former Philadelphia Energy Solutions rfinery site. Following the refinery's closure after a 2019 explosion, the property is being transformed into a life sciences, advanced manufacturing, and innovation hub. The project gained significant momentum after TerraPower Isotopes announced a $450 million investment to establish a medical isotope manufacturing facility supporting cancer treatment development. News source: https://www.wsj.com/articles/burned-out-philadelphia-refinery-finds-new-life-as-life-sciences-hub-10fbbe26 Found it interesting? Email: [email protected] US: +1 877 441 4866 DataM Intelligence has 10,000+ research reports serving across 100+ countries
Philadelphia Q2 2026 life sciences market report. 09 July 2026 Market highlights. * Overall vacancy increased by 260 basis points year over year to 7.3% from 4.7%. However, Philadelphia continues to post one of the lowest vacancy rates among the nation's leading life sciences markets. * Construction began on TerraPower Isotopes' 250,000-square-foot manufacturing facility at The Bellwether District, establishing the first life sciences tenant at the former Philadelphia Energy Solutions refinery redevelopment. * The Pew Charitable Trusts awarded $2.5 million to two Philadelphia organizations, including a $1.5 million grant to expand life sciences and healthcare workforce development across Southeastern Pennsylvania.